tm logo
CANNAFEN
Live/Registered
REGISTERED

on 16 Jun 2020

Last Applicant/ Owned by

City of London, London EC1V1NY

GB

Serial Number

79246444 filed on 05th Oct 2018

Registration Number

6077024 registered on 16th Jun 2020

in the Principal Register

Correspondent Address

Senzer Limited

2 Angel Square

London EC1V1NY

UNITED KINGDOM

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

CANNAFEN

Inhalers for medical purposes; medical inhalers; inhalers for medical use; inhalers for therapeutic use; therapeutic inhalers; inhalers for medical purposes, sold empty; all of the aforementioned goods either exclusively for use with cannabis that is solely synthetic in nature, or containing cannabis that is solely synthetic in nature Pharmaceutical preparations for inhalers for the treatment of Read More

Classification Information


Class [010]
Medical Instrument Products


Inhalers for medical purposes; medical inhalers; inhalers for medical use; inhalers for therapeutic use; therapeutic inhalers; inhalers for medical purposes, sold empty; all of the aforementioned goods either exclusively for use with cannabis that is solely synthetic in nature, or containing cannabis that is solely synthetic in nature

Class [005]
Pharmaceutical Products


Pharmaceutical preparations for inhalers for the treatment of pain, neuropathy, asthma, chronic obstructive pulmonary disease (copd), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, intestinal and cardiovascular disorders; pharmaceutical preparations and substances for use in chemotherapy; pharmaceutical preparations for inhalers for the treatment of pain, neuropathy, asthma, chronic obstructive pulmonary disease (copd), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, intestinal and cardiovascular disorders; drug delivery agents in the nature of tablets, liquid medications, inhalers, nasal and oral sprays that facilitate the delivery of a wide range of pharmaceuticals; Transdermal patches and transdermal patches for medical treatment, both for the treatment of pain, neuropathy, asthma, chronic obstructive pulmonary disease (copd), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, intestinal and cardiovascular disorders; all of the aforementioned goods containing cannabis that is solely synthetic in nature; sanitary preparations for medical purposes, vaccines, and sanitary sterilising preparations, all not containing cannabis or CBD

Mark Details


Serial Number

No 79246444

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
14th Sep 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED
14th Sep 2023WITHDRAWAL OF ATTORNEY GRANTED
09th Jan 2021FINAL DECISION TRANSACTION PROCESSED BY IB
04th Oct 2020FINAL DISPOSITION PROCESSED
04th Oct 2020FINAL DISPOSITION NOTICE SENT TO IB
16th Sep 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
16th Jun 2020REGISTERED-PRINCIPAL REGISTER
15th May 2020NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
29th Apr 2020NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
29th Apr 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB